Literature DB >> 19211358

[Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma].

J-C Trinchet1, A Alperovitch, P Bedossa, F Degos, P Hainaut, B Van Beers.   

Abstract

Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer and occurs mainly in patients with cirrhosis. This work aimed at reviewing the main data and trends about HCC epidemiology in France, and about prevention, screening and diagnosis in patients with chronic liver diseases. The six following research topics were considered as priorities: 1) to improve epidemiological knowledge of HCC in France; 2) to clarify the epidemiology of HCC occuring in normal liver and to identify predictive factors; 3) to prevent cancer occurrence in patients with cirrhosis; 4) to improve the knowledge of predictive factors for HCC occurrence in patients with cirrhosis; 5) to improve the diagnostic procedure of nodules below 2 cm in diameter in patients with cirrhosis; 6) to understand functioning of medical networks in order to identify the reasons for late diagnosis and treatment of HCC in patients with cirrhosis.

Entities:  

Mesh:

Year:  2009        PMID: 19211358     DOI: 10.1684/bdc.2009.0791

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  9 in total

1.  Changes in the urine volatile metabolome throughout growth of transplanted hepatocarcinoma.

Authors:  M Yu Kochevalina; A B Bukharina; V G Trunov; A V Pento; O V Morozova; G A Kogun'; Ya O Simanovsky; S M Nikiforov; E I Rodionova
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

2.  Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC).

Authors:  Kyeong-Ah Lee; Ji-Young Ahn; Sang-Hee Lee; Simranjeet Singh Sekhon; Dae-Ghon Kim; Jiho Min; Yang-Hoon Kim
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

3.  [Incidence of hepatocellular carcinoma in chronic infection with hepatitis B].

Authors:  Rénovat Ntagirabiri; Bélyse Munezero; Hippolyte Kaze; Eugène Ndirahisha; Sébastien Manirakiza
Journal:  Pan Afr Med J       Date:  2015-02-23

4.  Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study.

Authors:  Li-Shuai Qu; Fei Jin; Yan-Mei Guo; Tao-Tao Liu; Ru-Yi Xue; Xiao-Wu Huang; Min Xu; Tao-Yang Chen; Zheng-Ping Ni; Xi-Zhong Shen
Journal:  Oncol Lett       Date:  2015-11-23       Impact factor: 2.967

5.  Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma.

Authors:  Hossam Hodeib; Ola ELshora; Amal Selim; Nesreen Mohammed Sabry; Heba Mohamed El-Ashry
Journal:  Electron Physician       Date:  2017-01-25

Review 6.  Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta-analysis.

Authors:  Yu Zhang; Juan Tang; Xiao Zhou; Shao-Liang Zhu; Le-Qun Li
Journal:  Mol Genet Genomic Med       Date:  2019-11-27       Impact factor: 2.183

7.  Efficacy Evaluation on the Color Doppler Ultrasound, Multislice Spiral CT Combined with Serum Markers in Diagnosis of Primary Hepatic Carcinoma.

Authors:  Xiaolan Zhao; Yifang Xia; Chunjing Li; Dapeng Wang
Journal:  Iran J Public Health       Date:  2021-08       Impact factor: 1.429

Review 8.  Tumor markers for hepatocellular carcinoma.

Authors:  Yan-Jie Zhao; Qiang Ju; Guan-Cheng Li
Journal:  Mol Clin Oncol       Date:  2013-05-13

9.  Diagnostic and Prognostic Role of Serum Interleukin-6 in Malignant Transformation of Liver Cirrhosis.

Authors:  Mustafa Yakut; Hasan Özkan; Muhammed F Karakaya; Harun Erdal
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.